Last update 01 Nov 2024

Pharmaceutical aids

Last update 01 Nov 2024

Basic Info

Synonyms

Aids, Pharmaceutic, Aids, Pharmaceutical, Pharmaceutic Aids

+ [15]

Introduction

Substances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include SOLVENTS, diluting agents, and suspending agents, and emulsifying agents. Also, ANTIOXIDANTS; PRESERVATIVES, PHARMACEUTICAL; COLORING AGENTS; FLAVORING AGENTS; VEHICLES; EXCIPIENTS; OINTMENT BASES.

Drugs associated with Pharmaceutical aids

Polyethylene glycol 3350

Target-

Mechanism-

Active Org.

Bayer Healthcare LLC [+1]

Originator Org.

Braintree Ltd.

Active Indication

Constipation [+1]

Inactive Indication

Chronic constipation [+3]

Drug Highest PhaseApproved

First Approval Ctry. / Loc.

First Approval Date18 Feb 1999

Sodium Picosulfate Hydrate

Target-

Mechanism-

Active Org.

Viatris Healthcare GmbH [+3]

Originator Org.

Sanofi

Active Indication

Contrast agents [+2]

Inactive Indication

Constipation - functional [+3]

Drug Highest PhaseApproved

First Approval Ctry. / Loc.

First Approval Date27 Aug 1979

Acetaminophen

Target

COX

Mechanism

COX inhibitors

Active Org.

Hisamitsu Pharmaceutical Co., Inc. [+15]

Originator Org.

Dan Dong Yi Chuang Yao Ye You Xian Ze Ren Gong Si

Active Indication

Headache [+4]

Inactive Indication

Acute migraine [+21]

Drug Highest PhaseApproved

First Approval Ctry. / Loc.

First Approval Date01 Jan 1966

Clinical Trials associated with Pharmaceutical aids

JPRN-UMIN000046746 / Suspended

New construction of physical assessment online training program for pharmacists - New online physical assessment training for pharmacists

Start Date01 Mar 2022

Sponsor / Collaborator

Hokkaido University of Science

100 Clinical Results associated with Pharmaceutical aids

100 Translational Medicine associated with Pharmaceutical aids

0 Patents (Medical) associated with Pharmaceutical aids

Literatures (Medical) associated with Pharmaceutical aids

01 Sep 2022·Clinical Neurology and Neurosurgery

High expression of serum GST-π/CypA aids the diagnosis of acute cerebral infarction and predicts short-term poor prognosis

Article

Author: Wen, Xiulian ; Zhao, Ronghua

OBJECTIVEThe study examined the diagnostic and prognostic value of GST-π combined with CypA in acute cerebral infarction (ACI).METHODSThe study included 115 ACI patients and 85 healthy people. Expression patterns of serum GST-π and CypA were detected using ELISA. The diagnostic efficiency of GST-π, CypA, and GST-π combined with CypA on ACI was assessed by ROC curves. Pathological parameters were further analyzed using the Fisher test, t test, and one-way ANOVA. ACI patients were subsequently assigned into severe, moderate, and mild groups under the National Institutes of Health Stroke Scale (NIHSS), followed by Pearson analysis of the correlation between GST-π and CypA and NIHSS scores. The prognosis was evaluated by follow-up using modified Rankin Scale. Correlation between GST-π/CypA expression and ACI prognosis was predicted using a survival curve, and the predictive value of GST-π/CypA on ACI prognosis was assessed with a ROC curve. Lastly, the independent correlation of GST-π and CypA with poor ACI prognosis was analyzed with Logistics multivariate regression analysis.RESULTSGST-π and CypA were both highly-expressed in ACI patients. GST-π combined with CypA could better aid ACI diagnosis. Expressions of GST-π and CypA were positively correlated with NIHSS scores of ACI patients. High expressions of GST-π and CypA were correlated with poor short-term prognosis of ACI patients.CONCLUSIONSerum GST-π combined with CypA aids diagnosis and predicts poor short-term prognoses of ACI.DATA AVAILABILITYThe data that support the findings of this study are available from the corresponding author upon reasonable request.

01 Mar 1988·Archives of Pediatrics & Adolescent Medicine

AIDS, CHILDREN, AND PRIMARY CARE PHYSICIANS

Author: Ferrieri, Patricia

A wealth of medical literature has appeared on all aspects of the acquired immunodeficiency syndrome (AIDS) and the human immunodeficiency virus (HIV) since 1980. The output of information on AIDS during the past two years is only exceeded in my files by a collection of many years of reprints on the biology of streptococci and associated infections. I cannot possibly focus on all of the accumulated factual information on the biologic, epidemiologie, and clinical aspects of HIV and AIDS, but I wish to reflect on whether our profession is prepared to meet the multiple problems of children with AIDS. It has been estimated that as of Sept 30, 1987, 584 children 13 years of age or younger had met the case definition criteria of the Centers for Disease Control, Atlanta, for pediatrie AIDS (JAMA 1987;258:2736-2737). Furthermore, by 1991, an estimated 3000 children in the United States will have AIDS. This may be a severe underestimate. A disproportionate number of these children will be poor, black or Hispanic, and homeless.

Analysis

Perform a panoramic analysis of this field.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Pharmaceutical aids

Basic Info

Related

Analysis